Literature DB >> 30632108

Comment on: Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study.

Nuggehally R Srinivas1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30632108     DOI： 10.1007/s40261-018-0738-x

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  9 in total

Review 1.  Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride.

Authors:  Desmond Padhi; Robert Harris
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 2.  Does it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism?

Authors:  Jason R Stubbs; James B Wetmore
Journal:  Semin Dial       Date:  2011 May-Jun       Impact factor: 3.455

3.  Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl.

Authors:  Robert Z Harris; Margaret Salfi; Ed Posvar; David Hoelscher; Desmond Padhi
Journal:  Eur J Clin Pharmacol       Date:  2006-05-08       Impact factor: 2.953

Review 4.  Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.

Authors:  Pablo Ureña Torres
Journal:  J Ren Nutr       Date:  2006-07       Impact factor: 3.655

Review 5.  Cinacalcet hydrochloride.

Authors:  Julia A Barman Balfour; Lesley J Scott
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Effect of cinacalcet hydrochloride, a new calcimimetic agent, on the pharmacokinetics of dextromethorphan: in vitro and clinical studies.

Authors:  Daisuke Nakashima; Hirotaka Takama; Yuko Ogasawara; Tetsuyoshi Kawakami; Tsuyoshi Nishitoba; Sakuo Hoshi; Eiji Uchida; Hideji Tanaka
Journal:  J Clin Pharmacol       Date:  2007-07-24       Impact factor: 3.126

7.  Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole.

Authors:  Robert Z Harris; Margaret Salfi; John T Sullivan; Desmond Padhi
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  Assessment of CYP-Mediated Drug Interactions for Evocalcet, a New Calcimimetic Agent, Based on In Vitro Investigations and a Cocktail Study in Humans.

Authors:  Kazuya Narushima; Hiroshi Maeda; Masanari Shiramoto; Yuichi Endo; Satoko Ohtsuka; Hiroaki Nakamura; Yoshinori Nagata; Tatsuo Uchimura; Ayako Kannami; Ryutaro Shimazaki; Masafumi Fukagawa; Tadao Akizawa
Journal:  Clin Transl Sci       Date:  2018-10-24       Impact factor: 4.689

9.  Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study.

Authors:  Tadao Akizawa; Ryutaro Shimazaki; Masanari Shiramoto; Masafumi Fukagawa
Journal:  Clin Drug Investig       Date:  2018-10       Impact factor: 2.859
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.